The use of second-generation thrombopoietic agents for chemotherapy-induced thrombocytopenia Review uri icon

Overview

MeSH Major

  • Thrombocytopenia
  • Thrombopoiesis

abstract

  • The second generation of thrombopoietic agents has been shown to correct thrombocytopenia in selected diseases with a minimum of side effects. Looking forward, there is great potential for their use in other forms of thrombocytopenia, including chemotherapy-induced thrombocytopenia, but there are also many questions remaining regarding their best and safest use.

publication date

  • November 2008

Research

keywords

  • Review

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1097/CCO.0b013e32831369b2

PubMed ID

  • 18841052

Additional Document Info

start page

  • 690

end page

  • 6

volume

  • 20

number

  • 6